Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 2.40 |
| Low | 2.40 |
| Bid | -- |
| Offer | -- |
| Previous close | 2.30 |
| Average volume | 1.86k |
|---|---|
| Shares outstanding | 2.03m |
| Free float | 2.03m |
| P/E (TTM) | -- |
| Market cap | 4.51m USD |
| EPS (TTM) | -29.44 USD |
Data delayed at least 20 minutes, as of Feb 10 2026 17:22 GMT.
More ▼
Press releases
- Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai
- Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
- Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform
- Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships
- Co-Diagnostics Announces Reverse Stock Split
- Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
- Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
- Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation
- Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
- Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
More ▼
